# Neurovia, Inc.: Form D filings

Neurovia, Inc., a pharmaceuticals company in San Francisco, CA, filed 2 Form D notices with the SEC between 2015 and 2017. The latest, on May 25, 2017, reports $14 million sold of an offering with no set size to 8 investors.

Find out what Neurovia, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Neurovia%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Neurovia%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurovia-inc-1659474)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Neurovia%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Neurovia%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurovia-inc-1659474)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1700 OWENS STREET, SUITE 525, San Francisco, CA, 94158
- Phone: (415) 254-2232
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1659474

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 25, 2017 | Amendment | Indefinite | $13,950,000 | Indefinite | 8 | Nov 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1659474/000165947417000002/0001659474-17-000002-index.htm) |
| Dec 1, 2015 | New notice | Indefinite | $11,450,000 | Indefinite | 7 | Nov 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1659474/000165947415000001/0001659474-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Henry S. Skinner | Director |  |
| Thomas S. Scanlan | Executive Officer, Director |  |
| Giovanni Ferrara | Executive Officer, Director |  |
| Jason S. Hafler | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of May 22, 2017](https://specstream.ai/data/form-d/week/2017-05-22) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Neurovia, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).